Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome

Krystallenia Alexandraki, Athanasios D. Protogerou, Theodoros G. Papaioannou, Christina Piperi, George Mastorakos, John Lekakis, Dimitrios Panidis, Evanthia Diamanti-Kandarakis

Download PDF

OBJECTIVE: During the last decade cardiovascular risk factors and endothelial dysfunction have been shown to be present early in life in women with Polycystic Ovary Syndrome (PCOS). The aim of the present study was a global assessment of abnormalities in the arterial bed of young women with PCOS by non-invasive, reproducible methods…

The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration

Read More

Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome

Sofia Lazaridou, Konstantinos Dinas, Konstantinos Tziomalos

Download PDF

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age. PCOS is not only the leading cause of anovulatory infertility but is also associated with an array of metabolic disorders, among which impaired glucose metabolism has been a topic of intense research. The aim of the present narrative review is to summarize the findings of the studies that have evaluated the prevalence and incidence of prediabetes and type 2 diabetes mellitus …